Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference

Rhea-AI Summary

Optinose (OPTN) to present company overview and business update at 35th Annual Piper Sandler Healthcare Conference on November 29, 2023

YARDLEY, Pa., Nov. 22, 2023 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that members of its management team will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023, at 3:30 p.m. ET.

To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.

A replay of the webcast will be available for 60 days following the conclusion of the event.

About Optinose
Optinose is a specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on X and LinkedIn.

Optinose Investor Contact
Jonathan Neely
jonathan.neely@optinose.com
267.521.0531

FAQ

What is the event Optinose (OPTN) is participating in?

Optinose (OPTN) will present a company overview and business update at the 35th Annual Piper Sandler Healthcare Conference on November 29, 2023.

When is the presentation taking place?

The presentation will take place on November 29, 2023, at 3:30 p.m. ET.

How can I listen to the presentation live?

To listen to a webcast of the presentation live, visit the Investors page of the Optinose website.

Is there a replay available for the webcast?

Yes, a replay of the webcast will be available for 60 days following the conclusion of the event.